Patents by Inventor James R. Paterniti

James R. Paterniti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDE YY AND PEPTIDE YY AGONISTS FOR TREATMENT OF METABOLIC DISORDERS
    Publication number: 20140135261
    Abstract: Methods and compositions are disclosed to treat metabolic disorders such as obesity, diabetes, and increased cardiovascular risk comprising administering a therapeutically effective amount of a PYY or a PYY agonist.
    Type: Application
    Filed: January 24, 2014
    Publication date: May 15, 2014
    Applicants: ASTRAZENECA PHARMACEUTICALS LP, AMYLIN PHARMACEUTICALS, LLC
    Inventors: Richard A. PITTNER, Andrew A. YOUNG, James R. PATERNITI
  • Peptide YY and Peptide YY Agonists for Treatment of Metabolic Disorders
    Publication number: 20130023466
    Abstract: Methods and compositions are disclosed to treat metabolic disorders such as obesity, diabetes, and increased cardiovascular risk comprising administering a therapeutically effective amount of a PYY or a PYY agonist.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 24, 2013
    Applicant: Amylin Pharmaceuticals, LLC
    Inventors: Richard A. PITTNER, Andrew A. Young, James R. Paterniti, JR.
  • Methods of treating obesity using PYY[3-36]
    Patent number: 8273713
    Abstract: Methods and compositions are disclosed to treat metabolic disorders such as obesity, diabetes, and increased cardiovascular risk comprising administering a therapeutically effective amount of a PYY or a PYY agonist.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: September 25, 2012
    Assignee: Amylin Pharmaceuticals, LLC
    Inventors: Richard A. Pittner, Andrew A. Young, James R. Paterniti, Jr.
  • Peptide YY and peptide YY agonists for treatment of metabolic disorders
    Publication number: 20020141985
    Abstract: Methods and compositions are disclosed to treat metabolic disorders such as obesity, diabetes, and increased cardiovascular risk comprising administering a therapeutically effective amount of a PYY or a PYY agonist.
    Type: Application
    Filed: December 14, 2001
    Publication date: October 3, 2002
    Applicant: Amylin Parmaceuticals, Inc.
    Inventors: Richard A. Pittner, Andrew A. Young, James R. Paterniti